Literature DB >> 12705742

Kaposi's sarcoma: aetiopathogenesis, histology and clinical features.

F M Buonaguro1, M L Tornesello, L Buonaguro, R A Satriano, E Ruocco, G Castello, V Ruocco.   

Abstract

UNLABELLED: Kaposi's sarcoma (KS) represents today one of the most common skin cancers in transplanted Mediterranean subjects and, since the epidemic of human immunodeficiency virus/acquired immune deficiency syndrome, in young unmarried single men. The disease has been associated with the recent identified human herpesvirus (HHV)-8 or KS herpesvirus and its incidence in the general population shows a north to south gradient that parallels the HHV-8 increasing prevalence from Nordic countries to sub-Saharan regions. The identification of the aetiopathogenetic mechanisms (viral agents and immunodeficiency) involved in the pathogenesis of KS, are relevant for identifying susceptible subjects (HHV-8 seropositive subjects), monitoring the immune levels in iatrogenic immune suppressed patients, and developing new therapeutic approaches based on antiviral and immune modulators. LEARNING
OBJECTIVE: This article should enable the reader: (i) to learn about the clinical and molecular aspects of KS in order to have a multidisciplinary approach to a tumour that shows unique features; (ii) to consider the role of viral agents and immunity; and (iii) to recognize properties of an opportunistic neoplasm. The identification of the HHV-8 role in KS pathogenesis should establish a relevant tool in the clinical management of KS patients.

Entities:  

Mesh:

Year:  2003        PMID: 12705742     DOI: 10.1046/j.1468-3083.2003.00670.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.

Authors:  Sajad Varmazyar; Sayed Mahdi Marashi; Zabihollah Shoja; Maria Lina Tornesello; Franco M Buonaguro; Shohreh Shahmahmoodi; Zahra Safaie-Naraghi; Somayeh Jalilvand
Journal:  Med Microbiol Immunol       Date:  2017-01-12       Impact factor: 3.402

2.  Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran.

Authors:  Somayeh Jalilvand; Zabihollah Shoja; Talat Mokhtari-Azad; Rakhshandeh Nategh; Ahmad Gharehbaghian
Journal:  Infect Agent Cancer       Date:  2011-04-28       Impact factor: 2.965

Review 3.  Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.

Authors:  Eleonora Ruocco; Vincenzo Ruocco; Maria Lina Tornesello; Alessio Gambardella; Ronni Wolf; Franco M Buonaguro
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

4.  Epidemic, Endemic, or Stewart-Bluefarb? When Several Forms of Kaposi Seem to Dispute Paternity.

Authors:  Hugues Adegbidi; Bérénice Dégboé; Fabrice Akpadjan; Nadège Agbessi-Mekoun; Christiane Koudoukpo; Alida Kouassi; Félix Atadokpede
Journal:  Case Rep Dermatol Med       Date:  2020-04-09

5.  Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy.

Authors:  Alessia Villani; Gabriella Fabbrocini; Tiziana Peduto; Massimiliano Scalvenzi
Journal:  Dermatol Ther       Date:  2022-05-10       Impact factor: 3.858

6.  Clinical oncology in resource-limited settings.

Authors:  Franco M Buonaguro; Serigne N Gueye; Henry R Wabinga; Twalib A Ngoma; Jan B Vermorken; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2013-10-07       Impact factor: 2.965

Review 7.  Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan Patients.

Authors:  Noemy Starita; Clorinda Annunziata; Keith M Waddell; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411

8.  The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Authors:  Can Baykal; Tugba Atci; Nesimi Buyukbabani; Armagan Kutlay
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.